Ligand Pharmaceuticals Inc (LGND)

Total Costs & Expenses

$55.10M

Quarterly · Period ending: · USD

LGND logo

LGND Total Costs & Expenses

Latest reported$55.10M
LGND Quarterly Total Costs & Expenses ($7.90M → $55.10M)
High-resolution chart · PNG

LGND total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
25,154,000
25,401,000
23,246,000
24,027,000
24,348,000
22,370,000
24,100,000
24,900,000
25,200,000
23,000,000
28,200,000
20,800,000
20,600,000
17,700,000
23,700,000
20,500,000
19,300,000
18,900,000
20,200,000
17,100,000
17,400,000
14,900,000
15,300,000
14,300,000
0
8,700,000
9,600,000
8,500,000
8,200,000
7,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.